HD2A RASC - Pain Implementation Support Core
HD2A RASC - 疼痛实施支持核心
基本信息
- 批准号:10708984
- 负责人:
- 金额:$ 58.01万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-09-30 至 2027-08-31
- 项目状态:未结题
- 来源:
- 关键词:
项目摘要
PAIN IMPLEMENTATION SUPPORT CORE: PROJECT SUMMARY/ABSTRACT
The ongoing opioid overdose crisis – the leading cause of accidental deaths among Americans – has at its
roots inadequately treated opioid use disorder (OUD) and pain. This reality has been recognized by the
National Academy of Medicine and the Centers for Disease Control and Prevention, among other major
organizations charged with protecting the public health, sparking an unprecedented influx of funding and policy
changes to stem the tide of overdose deaths. The nationwide attention and funding increase have driven a
marked rise in the development of evidence-based, high-quality pain treatments and treatment guidelines
addressing the full spectrum of public health need: from prevention to harm reduction to treatment to recovery
support. However, there has been woefully inadequate uptake of these treatments in real-world practice. For
example, primary care providers--the most frequent prescribers of long-term opioid therapy for pain--often lack
skills and/or time to fully implement evidence-based guidelines, putting already vulnerable patients at even
higher risk for opioid-related harms, including overdose, and poorly-controlled chronic pain. Effectively
translating research findings into practice and ameliorating these real-world quality of care deficits are the
domains of dissemination and implementation (D&I) science. As a key RASC core, the overarching goal of the
Pain Implementation Support (Pain-IS) Core is to support HD2A Innovation Projects in successful
implementation of effective pain interventions through the coordinated efforts of a highly expert collaborative
team, deploying and advancing cutting edge D&I methods. We will bring the best of D&I science to the pain
treatment quality gap, unifying implementation scientists and pain researchers—with the proximal goal of
enhancing research in the Innovation Projects and the ultimate goal of impacting the public health. Specifically,
in alignment with the other Cores, we will ASSESS the current status of key components of the Innovation
Projects on D&I capability in 5 key dimensions: a) evidentiary basis for the intervention; b) stakeholder
engagement c) contextual determinants; d) selection of implementation strategies; and, e) implementation
outcomes including the critically important but often overlooked domain of equity. We will ASSIST the
Innovation Projects using the information gathered in the ASSESS phase in order to: a) enhance motivation to
enhance their studies with tailored D&I approaches that draw upon the Core’s expertise; b) provide a D&I
Implementation Support Plan on the components above and using a shared decision-making approach to
determine how best to offer technical assistance (implementation support); and, c) to co-lead the RASC
Learning Collaborative. In concert with the RASC and other cores, we will ADVANCE the innovation projects
activities with respect to sustainment and equity: linking projects with the field at large, promoting projects’
impacts on policy/financing, and facilitating ongoing stakeholder engagement towards advocacy.
疼痛实施支持核心:项目摘要/摘要
正在进行的阿片类药物过量危机 - 美国人意外死亡的主要原因 -
根部治疗的阿片类药物使用障碍(OUD)和疼痛不足。这个现实已被
国家医学院和疾病控制与预防中心,以及其他主要主要
负责保护公共卫生的组织,引发了资金和政策的前所未有的影响
改变过量死亡的潮流。全国范围内的关注和资金增加驱动了
循证,高质量疼痛治疗和治疗指南的开发显着增加
满足公共卫生需求的全部范围:从预防到损害减少到治疗,再到康复
支持。但是,在现实世界实践中,这些治疗方法的吸收不足。为了
例如,初级保健提供者 - 最常见的长期阿片类药物疗法的处方者,通常缺乏
技能和/或时间完全实施基于证据的准则,将已经脆弱的患者置于
阿片类药物相关危害的风险较高,包括过量服用和控制较差的慢性疼痛。有效地
将研究结果转化为实践,并改善这些现实的护理质量定义是
传播和实施(D&I)科学领域。作为关键的RASC核心,总的总体目标
疼痛实施支持(PAIN-IS)核心是成功支持HD2A创新项目
通过高度专家协作的协调努力实施有效的疼痛干预措施
团队,部署和推进前沿D&I方法。我们将把最好的D&I科学带来痛苦
治疗质量差距,统一实施科学家和痛苦研究人员,其代理目标的目标
增强创新项目的研究,以及影响公共卫生的最终目标。具体来说,
在与其他核心的一致性时,我们将评估创新关键组成部分的当前状态
D&I能力的项目在5个关键方面:a)干预的描述基础; b)利益相关者
参与c)上下文决定者; d)选择实施策略;并且,e)实施
结果包括至关重要但经常被忽视的公平领域。我们将协助
使用在评估阶段收集的信息来进行创新项目,以:a)增强动力
通过量身定制的D&I方法来增强他们的研究,从而利用核心的专业知识; b)提供D&I
在上述组件上实施支持计划,并使用共同的决策方法
确定如何最好地提供技术帮助(实施支持);并且,c)共同领导RASC
学习协作。与RASC和其他核心一致,我们将推进创新项目
关于维持和公平的活动:将项目与大型领域联系起来,促进项目
对政策/融资的影响,并支持正在进行的利益相关者参与倡导。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

暂无数据
数据更新时间:2024-06-01
WILLIAM C BECKER的其他基金
Multilevel Interventions to Reduce Harm and Improve Quality of Life for Patients on Long Term Opioid Therapy - Yale Resource Center (MIRHIQL-YRC)
多层次干预措施可减少长期阿片类药物治疗患者的伤害并提高其生活质量 - 耶鲁大学资源中心 (MIRHIQL-YRC)
- 批准号:1072276810722768
- 财政年份:2023
- 资助金额:$ 58.01万$ 58.01万
- 项目类别:
HD2A Research Adoption Support Center (RASC)
HD2A 研究采用支持中心 (RASC)
- 批准号:1070898010708980
- 财政年份:2022
- 资助金额:$ 58.01万$ 58.01万
- 项目类别:
Role of Non-pharmacological Pain Treatments in Safe and Effective Opioid Tapering in Chronic Pain
非药物疼痛治疗在安全有效地逐渐减少慢性疼痛中阿片类药物的作用
- 批准号:1062019510620195
- 财政年份:2022
- 资助金额:$ 58.01万$ 58.01万
- 项目类别:
HD2A RASC - Pain Implementation Support Core
HD2A RASC - 疼痛实施支持核心
- 批准号:1059643810596438
- 财政年份:2022
- 资助金额:$ 58.01万$ 58.01万
- 项目类别:
HD2A Research Adoption Support Center (RASC)
HD2A 研究采用支持中心 (RASC)
- 批准号:1059643510596435
- 财政年份:2022
- 资助金额:$ 58.01万$ 58.01万
- 项目类别:
HEAL Initiative: Integrative Management of chronic Pain and OUD for Whole Recovery (IMPOWR): Research Centers
HEAL 计划:慢性疼痛和 OUD 整体康复综合管理 (IMPOWR):研究中心
- 批准号:1087668210876682
- 财政年份:2021
- 资助金额:$ 58.01万$ 58.01万
- 项目类别:
HEAL Initiative: Integrative Management of chronic Pain and OUD for Whole Recovery (IMPOWR): Research Centers
HEAL 计划:慢性疼痛和 OUD 整体康复综合管理 (IMPOWR):研究中心
- 批准号:1065202710652027
- 财政年份:2021
- 资助金额:$ 58.01万$ 58.01万
- 项目类别:
HEAL Initiative: Integrative Management of chronic Pain and OUD for Whole Recovery (IMPOWR): Research Centers
HEAL 计划:慢性疼痛和 OUD 整体康复综合管理 (IMPOWR):研究中心
- 批准号:1037891010378910
- 财政年份:2021
- 资助金额:$ 58.01万$ 58.01万
- 项目类别:
Implementation of a Pragmatic Trial of Whole Health Team vs. Primary Care Group Education to Promote Non-Pharmacological Strategies to Improve Pain, Function and Quality of Life in Veterans
实施整体健康团队与初级保健团体教育的务实试验,以促进非药物策略,改善退伍军人的疼痛、功能和生活质量
- 批准号:1009056810090568
- 财政年份:2020
- 资助金额:$ 58.01万$ 58.01万
- 项目类别:
Implementation of a Pragmatic Trial of Whole Health Team vs. Primary Care Group Education to Promote Non-Pharmacological Strategies to Improve Pain, Function and Quality of Life in Veterans
实施整体健康团队与初级保健团体教育的务实试验,以促进非药物策略,改善退伍军人的疼痛、功能和生活质量
- 批准号:1053336110533361
- 财政年份:2020
- 资助金额:$ 58.01万$ 58.01万
- 项目类别:
相似国自然基金
多入口下穿隧道合流区域交通事故演化机理与自解释调控方法
- 批准号:52302437
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
源于随机行人碰撞事故边界反求的头部损伤评价准则及风险预测
- 批准号:52372348
- 批准年份:2023
- 资助金额:54 万元
- 项目类别:面上项目
面向救援与疏散的危化品储运灾害事故情景推演与应急态势评估方法
- 批准号:52374208
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
聚变堆真空室内失水事故射流闪蒸特性研究
- 批准号:12305183
- 批准年份:2023
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
燃料样品辐照流道堵塞事故演化机理及全堆响应研究
- 批准号:12375178
- 批准年份:2023
- 资助金额:52.00 万元
- 项目类别:面上项目
相似海外基金
A comparative evaluation of overdose prevention programs in New York City and Rhode Island
纽约市和罗德岛州药物过量预防计划的比较评估
- 批准号:1062974910629749
- 财政年份:2023
- 资助金额:$ 58.01万$ 58.01万
- 项目类别:
Radiation Mitigators Targeting Regulated Necrosis Pathways of Parthanatos Pyroptosis
针对帕塔纳托细胞焦亡的调节性坏死途径的辐射缓解剂
- 批准号:1083823210838232
- 财政年份:2023
- 资助金额:$ 58.01万$ 58.01万
- 项目类别:
Broad spectrum inhibitors of paramyxovirus envelope proteins
副粘病毒包膜蛋白的广谱抑制剂
- 批准号:1063436810634368
- 财政年份:2023
- 资助金额:$ 58.01万$ 58.01万
- 项目类别:
The role of adaptive immunity in organophosphate induced CNS injury
适应性免疫在有机磷诱导的中枢神经系统损伤中的作用
- 批准号:1062951110629511
- 财政年份:2023
- 资助金额:$ 58.01万$ 58.01万
- 项目类别:
Stress experiences as markers of person-level vulnerability and temporal risk for near-term suicidal ideation
压力体验是个人脆弱性和近期自杀意念暂时风险的标志
- 批准号:1082584710825847
- 财政年份:2023
- 资助金额:$ 58.01万$ 58.01万
- 项目类别: